Alumis, Inc. (ALMS)
6.03
+0.18
(+3.08%)
USD |
NASDAQ |
Nov 06, 16:00
6.015
-0.02
(-0.25%)
After-Hours: 20:00
Alumis Research and Development Expense (Annual) : 377.10M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 377.10M |
| December 31, 2024 | 262.40M |
| Date | Value |
|---|---|
| December 31, 2023 | 136.39M |
| December 31, 2022 | 101.05M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Corcept Therapeutics, Inc. | 254.91M |
| Aclaris Therapeutics, Inc. | 52.64M |
| BioAge Labs, Inc. | 73.97M |
| ANI Pharmaceuticals, Inc. | 51.66M |